Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-19

Clinical Trial Update: Radiotherapy Plus Hormone Therapy in Biochemically-relapsing Prostate Cancer Patients Following Surgery [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update evaluating radiotherapy plus hormone therapy in biochemically-relapsing prostate adenocarcinoma after radical prostatectomy (Phase 1/Phase…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hormone therapy
  • Radiotherapy

Snippet

Sponsor: UNICANCER | Conditions: Biochemically-relapsing Prostate Adenocarcinoma Following Radical Prostatectomy | Phase 1, Phase 2 | Status: COMPLETED